Pemetinib/pemetinib purchase channels and regular sales pharmacies
Pemigatinib is a targeted therapy drug mainly used to treat advanced cholangiocarcinoma (CCA) carrying FGFR2 gene rearrangements or mutations. The drug interferes with the growth signals of tumor cells by inhibiting the activity of fibroblast growth factor receptor (FGFR), thereby effectively inhibiting tumor development. During treatment, pemetinib demonstrated good efficacy and tolerability, especially in patients who have failed traditional treatments. In addition, the drug is currently under investigation and may be expanded to other FGFR-related tumor types.
Regarding the purchasing channels for pemetinib, patients can usually purchase it through regular medical institutions or pharmacies. Since pemetinib is not yet covered by national medical insurance, patients need to pay for it out of pocket. In China, the main specifications of pemetinib tablets are 4.5 mg 14 tablets and 9 mg 14 tablets, which can be found in pharmacies of some large hospitals. Before purchasing, it is best for patients to consult a doctor to confirm whether the drug is suitable for use and to obtain a relevant prescription.
In addition to hospital pharmacies, patients can also purchase pemetinib through some overseas pharmacies. These pharmacies often provide authenticity and quality assurance of medications to ensure patient safety. When choosing to purchase, patients should be cautious, ensure that the platform they choose has a legal business license, and check relevant user reviews to reduce the risk of purchasing counterfeit or inferior drugs.
In addition, when purchasing pemetinib, patients should not only pay attention to the price, but also confirm the validity period and storage conditions of the drug. When using pemetinib, patients should follow the doctor's guidance and conduct regular follow-up and monitoring in order to detect and deal with possible side effects in a timely manner and ensure the safety and effectiveness of the treatment.
Reference materials:https://go.drugbank.com/drugs/DB15102
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)